Louis Villain
Louis Villain publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering, on topics such as Protein purification and stability, Monoclonal and Polyclonal Antibodies Research and Viral Infectious Diseases and Gene Expression in Insects.
- World rank
- #6,460,496 of 7,710,434 ranked researchers
- Rank in Germany
- #325,289 of 364,343
- Works
- 26
- Citations
- 306
- Citations per work
- 11.8
What does Louis Villain research?
Louis Villain's work is mostly in Biochemistry, Genetics and Molecular Biology (46%), Medicine (19%), Engineering (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1245.8%
- Physical Sciences518.8%
- Engineering414.6%
- Environmental Science14.2%
- Health Sciences518.8%
- Medicine518.8%
- Everything else416.6%
- 1Molecular Biology38% of their works
- 2Radiology, Nuclear Medicine and Imaging15% of their works
- 3Biomedical Engineering15% of their works
- 4Genetics8% of their works
- 5Epidemiology4% of their works
- 6Water Science and Technology4% of their works
Research topics
- Protein purification and stability
- Monoclonal and Polyclonal Antibodies Research
- Viral Infectious Diseases and Gene Expression in Insects
- Virus-based gene therapy research
- 3D Printing in Biomedical Research
- Microfluidic and Capillary Electrophoresis Applications
- Innovative Microfluidic and Catalytic Techniques Innovation
- Membrane Separation Technologies
Which keywords describe Louis Villain's research?
The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Biopharmaceuticals, Glycosylation, Protein Aggregation, Antibody Engineering, Cell Culture and Fc Receptors.
- Tissue Engineering
- Microfluidics
- Lab-on-a-Chip
- Desalination
- Viral Vectors
- Recombinant Protein
- Fc Receptors
- Antibody Engineering
- Glycosylation
- Therapeutic Antibodies
- Monoclonal Antibodies
- Biopharmaceuticals
- Protein Aggregation
- Cell Culture
- Mammalian Cells
- Gene Therapy
- Bioprinting
- Droplet Formation
- Membrane Technology
- Poly(dimethylsiloxane)
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Monoclonal Antibodies192 topics
- Therapeutic Antibodies192 topics
- Biopharmaceuticals121 topic
- Glycosylation122 topics
- Protein Aggregation121 topic
- Antibody Engineering71 topic
- Cell Culture72 topics
- Fc Receptors71 topic
- Mammalian Cells51 topic
- Recombinant Protein51 topic
- Gene Therapy41 topic
- Viral Vectors41 topic
- Bioprinting21 topic
- Desalination21 topic
- Droplet Formation21 topic
- Lab-on-a-Chip21 topic
- Membrane Technology21 topic
- Microfluidics21 topic
- Poly(dimethylsiloxane)21 topic
- Tissue Engineering21 topic
Where does Louis Villain work?
Louis Villain's main affiliation in the publication record is Sartorius (Germany), Germany.
How many publications and citations does Louis Villain have?
OpenAlex counts 26 works and 306 citations for Louis Villain, an h-index of 12, ranking #6,460,496 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Louis Villain. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.